MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
KANT
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Kineta (KANT) Ownership - Who owns Kineta?

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.55M
P/E Ratio
N/A
Total Cash
900K
Projected Growth
N/A
Total Debt
710K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for KANT
Related Blogs
TECX

Tectonic Therapeutic (TECX) Narrows Q3 Loss to $1.08 Per Share With Extended Cash Runway

TOVX

Theriva Biologics (TOVX) Stock Drops -18% Over 30 Days Amid Financing Concerns

KURA

Kura Oncology (KURA) Q3 2026 Earnings: Watching the KOMZIFTI Launch Momentum

RNAC

Cartesian Therapeutics (RNAC) Reports Q3 Earnings Beat With Phase 3 Trial on Track

NBTX

Nanobiotix (NBTX): Assessing the Path to a $53 Target and +69% Upside

View all blogs related to
#Biotechnology
Interesting Articles

Can I Make Early Withdrawals From My 401(k)?

Is there any merit to technical analysis of the markets?

How Do I Allocate My Assets in Retirement?

What is an Abandonment Option?

What is an Account Number?

View all articles
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Who owns Kineta? KANT symbol Ownership - Tickeron.com